Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NICE (UK National Institute for Clinical Excellence): troponin test delays prompt PCI (percutaneous coronary intervention) policy review

This article was originally published in Clinica

Executive Summary

Delays in providing the results of cardiac troponin tests for patients being considered for percutaneous coronary intervention (PCI) has prompted the UK's National Institute for Clinical Excellence (NICE) to review its guidance on the use of drugs to reduce the risk of adverse cardiac events. The decision comes as the institute's Scottish counterpart - the Health Technology Board for Scotland - has begun to appraise troponin testing, with particular emphasis on point-of-care testing as a potential alternative (see page 5).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT068060

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel